Inovio Pharmaceuticals Stock Market Value

INO Stock  USD 13.95  0.92  7.06%   
Inovio Pharmaceuticals' market value is the price at which a share of Inovio Pharmaceuticals trades on a public exchange. It measures the collective expectations of Inovio Pharmaceuticals investors about its performance. Inovio Pharmaceuticals is selling at 13.95 as of the 28th of March 2024; that is 7.06 percent up since the beginning of the trading day. The stock's open price was 13.03.
With this module, you can estimate the performance of a buy and hold strategy of Inovio Pharmaceuticals and determine expected loss or profit from investing in Inovio Pharmaceuticals over a given investment horizon. Check out Inovio Pharmaceuticals Correlation, Inovio Pharmaceuticals Volatility and Inovio Pharmaceuticals Alpha and Beta module to complement your research on Inovio Pharmaceuticals.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
Symbol

Inovio Pharmaceuticals Price To Book Ratio

Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.09)
Revenue Per Share
0.038
Quarterly Revenue Growth
(0.18)
Return On Assets
(0.32)
Return On Equity
(0.80)
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Inovio Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Inovio Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Inovio Pharmaceuticals.
0.00
02/27/2024
No Change 0.00  0.0 
In 31 days
03/28/2024
0.00
If you would invest  0.00  in Inovio Pharmaceuticals on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Inovio Pharmaceuticals or generate 0.0% return on investment in Inovio Pharmaceuticals over 30 days. Inovio Pharmaceuticals is related to or competes with Pinterest, Herc Holdings, Broadstone Net, HE Equipment, Fortress Transp, Asure Software, and Sphere Entertainment. Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of D... More

Inovio Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Inovio Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Inovio Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Inovio Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Inovio Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Inovio Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Inovio Pharmaceuticals historical prices to predict the future Inovio Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Inovio Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
4.4512.1919.93
Details
Intrinsic
Valuation
LowRealHigh
0.306.0213.76
Details
Naive
Forecast
LowNextHigh
6.6214.3622.10
Details
5 Analysts
Consensus
LowTargetHigh
1.141.251.39
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inovio Pharmaceuticals. Your research has to be compared to or analyzed against Inovio Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Inovio Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Inovio Pharmaceuticals.

Inovio Pharmaceuticals Backtested Returns

Inovio Pharmaceuticals is risky given 3 months investment horizon. Inovio Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.2, which attests that the entity had a 0.2% return per unit of risk over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.53% are justified by taking the suggested risk. Use Inovio Pharmaceuticals Risk Adjusted Performance of 0.1362, downside deviation of 6.05, and Market Risk Adjusted Performance of 0.9408 to evaluate company specific risk that cannot be diversified away. Inovio Pharmaceuticals holds a performance score of 15 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.89, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inovio Pharmaceuticals will likely underperform. Use Inovio Pharmaceuticals maximum drawdown, as well as the relationship between the expected short fall and day median price , to analyze future returns on Inovio Pharmaceuticals.

Auto-correlation

    
  0.76  

Good predictability

Inovio Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Inovio Pharmaceuticals time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Inovio Pharmaceuticals price movement. The serial correlation of 0.76 indicates that around 76.0% of current Inovio Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.76
Spearman Rank Test0.81
Residual Average0.0
Price Variance1.08

Inovio Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Inovio Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Inovio Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Inovio Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Inovio Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Inovio Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Inovio Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Inovio Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Inovio Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Inovio Pharmaceuticals Lagged Returns

When evaluating Inovio Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Inovio Pharmaceuticals stock have on its future price. Inovio Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Inovio Pharmaceuticals autocorrelation shows the relationship between Inovio Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Inovio Pharmaceuticals.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock:
Check out Inovio Pharmaceuticals Correlation, Inovio Pharmaceuticals Volatility and Inovio Pharmaceuticals Alpha and Beta module to complement your research on Inovio Pharmaceuticals.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Inovio Stock analysis

When running Inovio Pharmaceuticals' price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Inovio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Inovio Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Inovio Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...